Image de couverture de livre

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Konstantinos Sechidis, Sophie Sun, Yao Chen, Jiarui Lu, Cong Zhang, Mark Baillie, David Ohlssen, Marc Vandemeulebroecke, Rob Hemmings, Stephen Ruberg, Björn Bornkamp
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Pharmaceutical Statistics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
par: Sechidis, Konstantinos, et autres
Publié: (2024)

Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
par: Björn Bornkamp, et autres
Publié: (2024)

Detection of Outlying Correlation Coefficients in Multicenter Clinical Trials
par: Lieven Desmet, et autres
Publié: (2025)

A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data
par: Ahrim Youn, et autres
Publié: (2024)

Principles for Defining Estimands in Clinical Trials—A Proposal
par: Tobias Mütze, et autres
Publié: (2024)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
par: Tomoyoshi Hatayama, et autres
Publié: (2025)

Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
par: Yulia Dyachkova, et autres
Publié: (2024)

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit
par: Yan Han, et autres
Publié: (2025)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
par: Zhiwei Zhang, et autres
Publié: (2025)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
par: Anders Granholm, et autres
Publié: (2025)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
par: Vahan Aslanyan, et autres
Publié: (2024)

Mediation Analysis of Path‐Specific Effects in Randomised Clinical Trials With Repeatedly Measured Mediators and Outcomes
par: Martin Linder, et autres
Publié: (2025)

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
par: Yueyang Han, et autres
Publié: (2025)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
par: Go Horiguchi, et autres
Publié: (2026)

Why “Minimal Clinically Important Difference” for Interpreting the Magnitude of the Treatment Effect Is Not Useful
par: Jitendra Ganju
Publié: (2025)

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
par: Sechidis, Konstantinos, et autres
Publié: (2025)

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
par: Konstantinos Sechidis, et autres
Publié: (2025)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
par: Yingjie Qiu, et autres
Publié: (2024)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
par: Ping Gao, et autres
Publié: (2025)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
par: Chiara Micoli, et autres
Publié: (2025)

A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial
par: Xiaofei Liu, et autres
Publié: (2026)

بیوتکنولوژی دارویی | اصول و کاربردها
par: Qalavand, Mostafa
Publié: (2025)

A Tree‐Based Scan Statistic for Detecting Signals of Drug–Drug Interactions in Spontaneous Reporting Databases
par: Seok‐Jae Heo, et autres
Publié: (2025)

Pre‐Posterior Distributions in Drug Development and Their Properties
par: Andrew P. Grieve
Publié: (2024)

Applying the Estimand Framework to Non‐Inferiority Trials
par: Helle Lynggaard, et autres
Publié: (2024)

Personalized Treatment Selection for Multivariate Ordinal Scale Outcomes and Multiple Treatments
par: Chathura Siriwardhana, et autres
Publié: (2025)

Variable Duration Trial as an Alternative Design for Continuous Endpoints
par: Jitendra Ganju, et autres
Publié: (2024)

Global Pharmaceutical Container Market 2025 To 2034
par: Sirsat, Nitin
Publié: (2025)

Estimation of Treatment Policy Estimands for Continuous Outcomes Using Off‐Treatment Sequential Multiple Imputation
par: Thomas Drury, et autres
Publié: (2024)

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
par: Jerome Sepin, et autres
Publié: (2025)

“Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation
par: Emilie Højbjerre‐Frandsen, et autres
Publié: (2026)

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
par: Yao Chen, et autres
Publié: (2026)

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups
par: Dan Jackson, et autres
Publié: (2024)

Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy
par: Sunita Rehal, et autres
Publié: (2026)

Machine Learning Approaches for Accelerating Drug Discovery and Reducing Clinical Trial Failures.
par: Sudhir, Siddharth
Publié: (2025)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
par: Gina D'Angelo, et autres
Publié: (2025)

Assessing the Operational Characteristics of the Individual Causal Association as a Metric of Surrogacy in the Binary Continuous Setting
par: Fenny Ong, et autres
Publié: (2024)

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
par: Jun Zhang, et autres
Publié: (2024)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
par: Dario Zocholl, et autres
Publié: (2025)

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment
par: Jixian Wang, et autres
Publié: (2025)